FDA Regulatory Toxicology Consulting
A Toxicologist’s Take on Why This Was Predictable—and Preventable
According to NewsNation, a New Jersey–based frozen food distributor has issued more than 50 recall notices after multiple products were linked to Salmonella contamination. The scope is extraordinary: dozens of products, multiple brands, nationwide distribution, and exposure across vulnerable populations.
(Source: NewsNation, 2025)
This is not just another recall story.
How QT Prolongation, hERG Blockade, and Drug Interactions Forced a Regulatory Reset
In the late 1990s, two blockbuster “non-sedating” antihistamines—terfenadine (Seldane) and astemizole—were pulled from the market after being linked to QT interval prolongation and torsades de pointes, a rare but often fatal heart rhythm disturbance.
How Muscle Toxicity, Drug Interactions, and Design Blind Spots Led to a Global Withdrawal
In 2001, Bayer withdrew cerivastatin—marketed as Baycol in the U.S. and Lipobay internationally—after mounting reports of rhabdomyolysis, a severe form of muscle breakdown that can lead to acute renal failure and death.
The consequences were immediate and severe: a global recall, thousands of adverse event reports, over 50 confirmed deaths, multibillion-dollar litigation settlements, and long-term reputational damage that weighed heavily on Bayer’s valuation for years.
The FDA has announced a nationwide recall of a widely used over-the-counter nasal spray after testing revealed contamination with pathogenic bacteria capable of causing serious infections. The recall followed multiple reports of sinus infections and systemic illness linked to the affected lots.Source: Health.com (2025) https://www.health.com/nasal-spray-recall-december-2025-11868374 This isn’t just a manufacturing lapse. It is a toxicology […]
To diagnose a circadian rhythm disorder, your doctor may review your medical history; ask about your symptoms, sleep patterns, and environment; do a physical exam; and order diagnostic tests.
According to MDLinx, Rofecoxib (Vioxx) — Merck’s blockbuster COX-2 selective anti-inflammatory drug — was withdrawn in 2004 after long-term clinical data revealed a significant increase in heart attack and stroke risk.
This single mechanistic toxicology failure erased more than $30 billion in market value, triggered historic litigation, and permanently reshaped FDA’s cardiovascular risk requirements.
How Troglitazone’s Hepatotoxicity Changed Drug Development Forever — and Why It Still Matters Today
Troglitazone (Rezulin), introduced by Warner-Lambert and later absorbed by Pfizer, was once celebrated as a breakthrough insulin-sensitizing therapy for type 2 diabetes. Within a few years, it became one of the most catastrophic toxicology failures in FDA history — linked to idiosyncratic yet sometimes fatal liver injury, multiple cases of acute liver failure, and a full U.S. market withdrawal in 2000.
According to The Hill, a widely used high-blood-pressure medication was voluntarily recalled after FDA testing identified contamination and quality issues that could pose serious risks to patients.
https://thehill.com/policy/healthcare/5636604-high-blood-pressure-medication-voluntarily-recalled-fda
Why do these recalls keep happening?
Because wherever chemistry, manufacturing, and patient exposure intersect — toxicology decides the outcome.
Here’s the one idea you should take away:
Pharmaceuticals enter the environment via patient excretion, improper disposal, and manufacturing waste, prompting regulators worldwide to require environmental risk assessments (ERAs) as part of drug approvals. In an ERA, predicted environmental concentrations (PECs) of a drug are compared to ecotoxicity thresholds, often in a tiered fashion (Phase I screening followed by Phase II testing) [1]. This report analyzes ERA regulations and practice globally, from the EU and US to emerging regions in Asia, Latin America, the Middle East, and Africa. It integrates recent developments in China, India, Brazil, the Gulf Cooperation Council (GCC) countries, ASEAN nations, and African markets, alongside established frameworks (EU, US, Canada, Japan, Australia). Key findings include:
